While only Europe’s 34th biggest country by landmass and 13th by population, Belgium punches well above its weight in terms of key life sciences industry indicators, notably placing in the Top Five European countries for pharma R&D spending, pharma exports, and pharma imports.
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
The top 20 pharma companies in Belgium ranked by revenue for the financial year 2019. EG Generics is way out in front with EUR 210 million in revenue, followed by…
Belgium, with a total of EUR 5.5 billion in R&D spending in 2021, is the country with the fourth largest research expenditure in the EU and the first per inhabitant. …
The Belgian retail market continues to grow in value, while decreasing slightly in volume, to reach a total of EUR 3.16 billion by the end of 2019. Made with…
An overview of health and healthcare in Belgium with data on the country’s leading causes of death, healthcare expenditure and hospital infrastructure. The top 10 causes of death in…
A roundup of some of the biggest pharma news from Belgium including Neuraxpharm’s new Belgian affiliate, Novalis Biotech’s investment in Rarity Bioscience, Catalent’s plasmid DNA manufacturing site and a recent…
Writing in the special December 2022 edition of DIA’s Global Forum magazine, Eli Lilly’s Mark Mayer, Pfizer’s Nick Sykes and Julie O’Brien, and the EFPIA’s Sini Eskola, Magda Chlebus, and…
EUCOPE’s Secretary-General Dr. Alexander Natz sees both opportunities and pitfalls with the EU HTA procedure, saying that the next three years will decide the crucial steps and whether the new…
See our Cookie Privacy Policy Here